Zaid Almarzooq, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 3 | 2023 | 1287 | 1.090 |
Why?
|
Aortic Valve Stenosis | 6 | 2023 | 2023 | 1.040 |
Why?
|
Lipoprotein(a) | 2 | 2023 | 489 | 0.740 |
Why?
|
Myocardial Infarction | 5 | 2023 | 11513 | 0.730 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2024 | 1564 | 0.700 |
Why?
|
Troponin | 2 | 2020 | 536 | 0.680 |
Why?
|
Heart Valve Prosthesis | 2 | 2023 | 1464 | 0.580 |
Why?
|
Education, Distance | 1 | 2020 | 260 | 0.530 |
Why?
|
Cardiovascular System | 1 | 2024 | 839 | 0.530 |
Why?
|
Pulmonary Embolism | 3 | 2023 | 2596 | 0.480 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1145 | 0.480 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 594 | 0.480 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2020 | 611 | 0.470 |
Why?
|
Echocardiography, Transesophageal | 1 | 2020 | 1093 | 0.450 |
Why?
|
Calcinosis | 1 | 2022 | 1480 | 0.440 |
Why?
|
Aortic Valve | 6 | 2023 | 1966 | 0.380 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2418 | 0.370 |
Why?
|
Population Surveillance | 1 | 2021 | 2594 | 0.360 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2186 | 0.350 |
Why?
|
Stroke | 6 | 2024 | 9741 | 0.350 |
Why?
|
Kidney Failure, Chronic | 2 | 2021 | 2505 | 0.320 |
Why?
|
Brain Ischemia | 1 | 2022 | 3001 | 0.320 |
Why?
|
Heart Failure | 8 | 2024 | 11882 | 0.310 |
Why?
|
Coronary Disease | 1 | 2022 | 5915 | 0.290 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3935 | 0.270 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3250 | 0.260 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5887 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3110 | 0.250 |
Why?
|
Heart Diseases | 3 | 2024 | 2817 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3232 | 0.250 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15657 | 0.240 |
Why?
|
Outpatients | 2 | 2024 | 1596 | 0.240 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6558 | 0.230 |
Why?
|
Prosthesis Design | 2 | 2023 | 2120 | 0.230 |
Why?
|
United States | 16 | 2024 | 72951 | 0.230 |
Why?
|
Medicare | 6 | 2024 | 6820 | 0.230 |
Why?
|
Humans | 40 | 2024 | 766766 | 0.200 |
Why?
|
Treatment Outcome | 11 | 2024 | 65273 | 0.200 |
Why?
|
Embolectomy | 1 | 2023 | 130 | 0.200 |
Why?
|
Pandemics | 2 | 2020 | 8735 | 0.180 |
Why?
|
Republic of Korea | 1 | 2023 | 591 | 0.180 |
Why?
|
Internship and Residency | 1 | 2021 | 5943 | 0.180 |
Why?
|
Catheters | 1 | 2023 | 428 | 0.170 |
Why?
|
Thrombolytic Therapy | 3 | 2023 | 2053 | 0.170 |
Why?
|
Venous Thromboembolism | 2 | 2023 | 1882 | 0.170 |
Why?
|
Thrombosis | 2 | 2024 | 2953 | 0.160 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2030 | 0.160 |
Why?
|
Risk Factors | 9 | 2024 | 74881 | 0.160 |
Why?
|
Heart | 2 | 2022 | 4425 | 0.150 |
Why?
|
Aged | 17 | 2024 | 171343 | 0.150 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 575 | 0.150 |
Why?
|
Shock, Cardiogenic | 1 | 2023 | 709 | 0.140 |
Why?
|
Stroke Volume | 4 | 2021 | 5618 | 0.140 |
Why?
|
Albuminuria | 1 | 2020 | 659 | 0.130 |
Why?
|
Anticoagulants | 2 | 2023 | 4855 | 0.130 |
Why?
|
Regression Analysis | 2 | 2024 | 6329 | 0.130 |
Why?
|
Mitral Valve | 1 | 2024 | 1473 | 0.130 |
Why?
|
Registries | 3 | 2024 | 8351 | 0.130 |
Why?
|
Morbidity | 1 | 2021 | 1754 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2020 | 571 | 0.130 |
Why?
|
Mitral Valve Insufficiency | 1 | 2024 | 1414 | 0.120 |
Why?
|
Blood Pressure | 3 | 2020 | 8533 | 0.120 |
Why?
|
Tetrazoles | 1 | 2021 | 923 | 0.120 |
Why?
|
Hemorrhage | 2 | 2023 | 3464 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1003 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1065 | 0.110 |
Why?
|
Mammary Arteries | 1 | 2014 | 81 | 0.110 |
Why?
|
Male | 19 | 2024 | 364142 | 0.110 |
Why?
|
American Heart Association | 3 | 2024 | 1049 | 0.110 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2078 | 0.110 |
Why?
|
Female | 19 | 2024 | 396520 | 0.100 |
Why?
|
Mortality | 2 | 2021 | 2910 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2017 | 5343 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2022 | 2234 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2021 | 1790 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3135 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2023 | 2763 | 0.090 |
Why?
|
Kidney | 2 | 2024 | 7074 | 0.090 |
Why?
|
Prognosis | 2 | 2021 | 29948 | 0.090 |
Why?
|
Health Behavior | 1 | 2022 | 2649 | 0.090 |
Why?
|
Hypertension | 3 | 2019 | 8616 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3832 | 0.090 |
Why?
|
Hospitalization | 3 | 2021 | 10823 | 0.080 |
Why?
|
Recurrence | 1 | 2020 | 8507 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15908 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3850 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2188 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5945 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2520 | 0.060 |
Why?
|
Patient Discharge | 1 | 2016 | 3465 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15416 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2018 | 5182 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39309 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26310 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 223257 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2022 | 81635 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 13050 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16724 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20708 | 0.040 |
Why?
|
Adult | 7 | 2024 | 223307 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59550 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24295 | 0.040 |
Why?
|
Acute Disease | 2 | 2022 | 7241 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2024 | 849 | 0.040 |
Why?
|
Home Care Services | 1 | 2024 | 659 | 0.040 |
Why?
|
Length of Stay | 2 | 2024 | 6490 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8891 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2022 | 935 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 1026 | 0.030 |
Why?
|
Time Factors | 3 | 2024 | 40149 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 54871 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2085 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1321 | 0.030 |
Why?
|
Survival Rate | 2 | 2022 | 12825 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1750 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2024 | 2184 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10580 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2022 | 1456 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2232 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2274 | 0.020 |
Why?
|
Vascular Patency | 1 | 2014 | 915 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3434 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3070 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2869 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3716 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5143 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1514 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3799 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10384 | 0.020 |
Why?
|
Adolescent | 3 | 2023 | 88904 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21525 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 41710 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12064 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10619 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7871 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30237 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 13090 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8066 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 59939 | 0.010 |
Why?
|